1. Home
  2. NBN vs JANX Comparison

NBN vs JANX Comparison

Compare NBN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$124.45

Market Cap

836.7M

Sector

Finance

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.29

Market Cap

890.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBN
JANX
Founded
1872
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.7M
890.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NBN
JANX
Price
$124.45
$13.29
Analyst Decision
Hold
Buy
Analyst Count
1
12
Target Price
$102.00
$57.36
AVG Volume (30 Days)
113.4K
1.7M
Earning Date
01-26-2026
02-26-2026
Dividend Yield
0.03%
N/A
EPS Growth
20.54
N/A
EPS
10.36
N/A
Revenue
$213,090,000.00
$10,000,000.00
Revenue This Year
$11.59
N/A
Revenue Next Year
$11.26
N/A
P/E Ratio
$12.09
N/A
Revenue Growth
23.79
N/A
52 Week Low
$78.17
$12.12
52 Week High
$126.26
$44.83

Technical Indicators

Market Signals
Indicator
NBN
JANX
Relative Strength Index (RSI) 66.47 36.48
Support Level $118.94 $12.12
Resistance Level $126.26 $14.16
Average True Range (ATR) 4.75 0.75
MACD 0.33 0.04
Stochastic Oscillator 83.88 17.66

Price Performance

Historical Comparison
NBN
JANX

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: